What SATTLutech does

SATT Lutech SAS is a French technology transfer accelerator (Société par actions simplifiée) founded in 2012 and headquartered in Paris, operating as the exclusive transfer vehicle for the Alliance Sorbonne Université. It detects, protects, develops, and markets academic research outputs sourced from approximately 8,350 researchers across founding institutions including Sorbonne Université, CNRS, UTC, MNHN, ENSCI, and Université Paris Panthéon Assas. Its service platform spans four researcher-facing offers (Soutien, Licensing, Maturation, Entreprenariat) and three enterprise-facing offers (Exploration, Synergie with up to €300K financing, and Stratégie with up to €600K financing), guiding projects through analysis, IP protection, maturation, and transfer.

The organization's portfolio covers biotech, medtech, digital/engineering, greentech, and social sciences, with 13+ actively marketed technology sheets (CryoBlood non-toxic cryopreservation, Iridiosol PEM catalyst, SyncLock RF security, IL-1 Allergie immunotherapy, Tabullaria and Fibula prosthetics, Coum'Activ synucleinopathy therapy, COVEM respiratory monitoring, GEAT cardiac biomarker, InjectCell, MITools EEG analytics, IDEM gesture capture, CHRONOS HD-EMG grid) and 20+ supported startups including Biophytis (IPO), Bodycap, Qubit Pharmaceuticals, Biomemory, 4Moving Biotech, Imageens, and Mirega. To date, SATT Lutech has invested €62M across 641 projects (233 currently in maturation) and recorded 128 successful technology transfers.

SATT Lutech's revenue model combines technology licensing (upfronts, milestones, royalties), equity stakes in spin-off startups (realized through exits or subsequent funding rounds), public maturation funding administered via Bpifrance's Deeptech Plan, and professional services for IP strategy and deal structuring. It is part of the national Réseau SATT of 13 technology transfer accelerators connected to over 150,000 researchers, and its institutional shareholders include Bpifrance alongside the six founding academic institutions.

Name

SATTLutech

Legal name

SATT Lutech SAS

Website

https://sattlutech.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

SATT Lutech is the Paris-based technology transfer accelerator for Alliance Sorbonne Université, licensing academic research and creating startups across biotech, medtech, digital, and greentech, with 641 projects invested and 128 completed transfers to date.

Ownership category

akta.pro rank

Product category

Technology Transfer Services

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (541690), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Engineering Services (8711), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Technology Transfer & Innovation-Driven Research Universities (High Commercialization) (EDAHABAH)

akta.pro secondary industries

Applied Research & Innovation Universities (EDAHAEAE), Technical Universities with Specialized Engineering Domains (EDAHAEAI)

Keywords

• Technology transfer services
• Academic research commercialization
• Patent licensing services
• Startup incubation programs
• Innovation maturation funding

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Technology Licensing: SATT Lutech generates revenue through licensing agreements with companies for technologies transferred from public research. This includes licensing of patents, software, and know-how developed in research laboratories. Licensing models include exclusive and non-exclusive arrangements with upfront payments, milestones, and royalties.
2. Startup Equity: SATT Lutech supports creation of spin-off startups from research and retains equity stakes in these companies. Revenue is generated through successful exits, IPOs, or subsequent funding rounds where SATT's equity is diluted or sold.
3. Maturation Funding: SATT Lutech invests in technology maturation projects (641 projects invested including 233 in maturation) using public funding. Returns are generated when matured technologies are transferred to industry or startups. Programs include co-maturation with companies (up to €300K for Synergie track, up to €600K for Stratégie track).
4. Professional Services: SATT Lutech provides accompaniment services including IP strategy, market analysis, deal structuring, and project management. These services support technology transfer transactions and help structure deals between researchers and industrial partners.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

SATT Lutech is a technology transfer accelerator for the Alliance Sorbonne Université that detects, protects, develops, and markets academic research results through IP protection, technology maturation funding, licensing to industry, and startup creation. It offers structured accompaniment tracks for researchers (Soutien, Licensing, Maturation, Entreprenariat) and enterprise engagement programs (Exploration, Synergie up to €300K, Stratégie up to €600K), supported by a portfolio of licensable technology projects (fiches techno) across biotech, medtech, greentech, digital engineering, and SHS.

Product overview

SATT Lutech is a technology transfer accelerator for the Alliance Sorbonne Université operating as a platform with multiple service modules and a portfolio of technology projects (fiches techno) and supported startups. Core services include four researcher support offers (Soutien, Licensing, Maturation, Entreprenariat) and three enterprise engagement offers (Exploration, Synergie, Stratégie) that guide innovations from academic research through IP protection, maturation, and market transfer. The product portfolio spans multiple sectors—Biotech, MedTech, Greentech, Numérique et ingénierie (Digital and Engineering), and SHS—featuring 13+ technology sheets including Cryoblood (cryopreservation), Iridiosol (hydrogen catalyst), SyncLock (RF security), IL-1 Allergie (immunotherapy), Tabullaria (prosthetic socket), Coum'Activ (neurodegenerative therapy), COVEM (respiratory detection), MITools (EEG diagnostics), and IDEM (gesture learning), plus 20+ supported startups.

Differentiator

Problem solved

Functional benefit

Products and services

• Accompagnement SATT Lutech (Technology Transfer Accompaniment) End-to-end technology transfer acceleration service for academic researchers, industrial companies, and investors, guiding innovations through detection, IP protection, maturation, and commercialization stages.
• Offre Soutien (Support Offer) Expertise and consultation services for research establishments on specific technology transfer topics and future transfer clauses.
• Offre Licensing IP strategy, licensing model definition, deal negotiation, contract drafting, and post-contract follow-up for researchers with projects transferring to identified industrial partners.
• Offre Maturation Commercial prospecting, market studies, and technology maturation programs for projects transferring to market without identified industrial partners.
• Offre Entreprenariat Startup creation support including positioning, investor and incubator connections, and deal negotiation for researchers seeking to create companies from academic research.
• Offre Exploration (Enterprise) Quick technology testing track allowing enterprises to evaluate technical relevance of academic technologies with no financial commitment and direct research team interaction.
• Offre Synergie (Enterprise Co-maturation) Co-construction of co-maturation programs with enterprises including up to €300K financing, co-ownership of generated assets, exclusive licensing option, reduced PI costs during co-maturation, and reduced upfront if exploitation contract is concluded before end of co-maturation.
• Offre Stratégie (Enterprise Co-development) Co-development of technologies at advanced development stages with up to €600K financing, free exclusive licensing option, symbolic upfront, no annual minimum guarantees, and adjusted royalty rates based on investment level.
• Cryoblood Non-toxic directional cryopreservation method using directed freezing for cells freely suspended in isotonic aqueous solution, eliminating conventional toxic cryoprotectants like DMSO or glycerol. Targets medical biobanks, cell therapy, ART, and academic research.
• Iridiosol More efficient PEM electrolysis anode catalyst using porous microspheres of iridium oxide with unique morphology and extended accessible surface area, requiring 10 times less iridium for the same current density versus voltage.
• SyncLock Anti-counterfeiting security solution protecting integrated circuits of RF transceivers using synchronization-based locking with hard-coded error corrected by secret key, providing maximum security against all known attacks with no performance penalty.
• IL-1 Allergie Allergen immunotherapy technology using interleukin-1 (IL-1) to rebalance immune responses, shifting response toward IgG and up-regulating FcγRIIb inhibitory receptors on mast cells to reduce reactivity to allergens. Targets the ~$31.6 billion global allergen immunotherapy market.
• Tabullaria Adaptable prosthetic socket device based on new materials that adapts to stump volume variations in real-time for better pressure distribution and vascularization, reducing shocks, vibrations, and pistoning effects in tibial prostheses.
• Coum'Activ First-in-class therapeutic approach for synucleinopathies that actively eliminates pathological alpha-synuclein aggregates through selective activation of KLK6 (neurosin), targeting Parkinson's disease, Dementia with Lewy Bodies, and Multiple System Atrophy.
• COVEM Multimodal respiratory disorder detection device aggregating ECG, EEG, movement, and respiratory rate signals to detect changes in patient respiratory status, automatically modify respiratory system parameters, and alert medical staff in case of dyspnea.
• MITools Software for analyzing biomarkers of cortical dysfunction in neurological diseases through EEG signal processing, acquiring raw EEG signals and removing artifacts using visual ICA tool via user-friendly interface for early diagnosis of neurodegenerative diseases.
• IDEM Scanner composed of cameras and software capturing trajectory of movement and displaying it in 4D (3 physical dimensions plus speed), non-invasively with no sensors on filmed subject, intended as tool for learning complex gestures with reference comparison.
• Fibula Modular bioinspired tibial prosthesis comprising a stem and ground support block connected by a linking system, providing biomechanically ergonomic leg function close to natural walking with easy assembly/disassembly for changing physical activities and morphologies.
• Cyclope Intelligent endoscopic capsule with embedded image processing, optimized acquisition, and improved autonomy for colorectal cancer screening, developed through co-maturation with BodyCap and LIP6 (Sorbonne Université computer science laboratory).
• Polype Software solution for automatic polyp detection and medical report generation supporting colorectal cancer diagnosis through AI-based image analysis.
• CHRONOS Novel HD-EMG grid design integrating with existing hardware technology for assessing muscle health via ambulatory device measuring and analyzing HD-EMG signals using AI-based software, targeting early aging, sarcopenia, and post-hip prosthesis recovery evaluation.
• InjectCell Device allowing injection of soft tissues (agar plates, cell sheets) through minimal subretinal incision, greatly reducing invasiveness and maximizing preservation of retinal structures; can also implant flexible biological or artificial tissue into or under living organs.
• GEAT Method for assessing risk of developing atrial cardiomyopathy in diabetic patients using MRI to assess epicardial adipose tissue around groove sulcus and analyze atrial deformation, providing subclinical disease detection and predictive information.
• Startups Portfolio Portfolio of 20+ spin-off startups supported by SATT Lutech including 4Moving Biotech, Alifert, Biomemory, Biophytis, Bodycap, Imageens, Mirega, Qubit Pharmaceuticals, Robeauté, Seamless Waves, and others spanning biotech, medtech, digital engineering, and greentech.

Quantifiable outcome

• 62M€ invested in 641 projects with 128 successful transfers
• +6 more outcomes

Named customers23 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature13 records

Partnerships

16 partnerships are on record, tiered major, core and minor.

• Groupe CARSOmajorStrategic or Co-development Partner · 1 January 2025Water analysis market leader and comaturateur of MicroSense technology for automated water quality monitoring. Won 2025 Innovation Trophies.
• Neurodyx TherapeuticsmajorStrategic or Co-development Partner · 1 January 2025Company founded to pursue preclinical and clinical development of neuroprotective peptide for neurodegenerative diseases (Parkinson's). Sourced from research by Daniel Dunia and Stephane Hunot.
• BodyCapmajorStrategic or Co-development Partner · 1 December 2023Co-maturation partner on Cyclope and Polype projects since December 2023. Expert in miniaturized sensors working with LIP6 laboratory on AI-embedded endoscopic capsules for colorectal cancer detection.
• LIP6 (Laboratoire d'Informatique de Paris 6)majorStrategic or Co-development Partner · 1 December 2023Computer science laboratory at Sorbonne Université. Joint development of Cyclope endoscopic capsule and Polype diagnostic software with expertise in electronic architectures and AI.
• ICI-Lab (Intelligence Artificielle Embarquée & Capsules Ingérables)majorStrategic or Co-development Partner · 1 December 2023Joint laboratory co-founded in December 2023 by BodyCAP and LIP6 for automatic image analysis, polyp detection, and innovative sensor integration (gas, pH, microbiota).
• Sorbonne UniversitécoreStrategic or Co-development PartnerPrimary research institution and founding shareholder. Main source of research projects and talent pipeline for technology transfer.
• CNRS (Centre National de la Recherche Scientifique)coreStrategic or Co-development PartnerMajor French research organization and shareholder. Key source of research innovations and co-development partner.
• Université de Technologie de Compiègne (UTC)coreStrategic or Co-development PartnerTechnical university shareholder contributing engineering and technology research projects.
• Muséum National d'Histoire Naturelle (MNHN)coreStrategic or Co-development PartnerNatural history museum and research institution shareholder contributing life sciences and environmental research.
• ENSCI - Les AtelierscoreStrategic or Co-development PartnerDesign school shareholder contributing design and creative industry research projects.
• Université Paris Panthéon AssascoreStrategic or Co-development PartnerLaw and economics university shareholder contributing legal and business expertise.
• 4P-PharmamajorStrategic or Co-development PartnerCo-maturation partner with SATT Lutech for 4Moving Biotech osteoarthritis treatment. Created subsidiary 4Moving Biotech in 2017 for clinical development.
• AgoranovminorImplementation/ SI/ Consulting PartnerStartup incubator located in Cité de l'Innovation. Provides incubation services for spin-off companies from Sorbonne Université ecosystem.
• Cité de l'InnovationcoreStrategic or Co-development PartnerInnovation campus under development in Paris gathering Sorbonne Université's innovation ecosystem, including SATT Lutech, Agoranov incubator, and deeptech startups.
• Pôle Universitaire d'Innovation Alliance Sorbonne UniversitécoreStrategic or Co-development PartnerUniversity Innovation Pole placing innovation at the heart of Sorbonne Université research. Covers all disciplines from humanities to sciences, medicine, engineering, design, and management.
• Réseau SATTcoreStrategic or Co-development PartnerNational network of 13 French Technology Transfer Acceleration Companies. Connected to 150,000+ researchers. First actors of the national Deeptech Plan operated by Bpifrance. Created 900+ startups.

Scale indicators16 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• CNRS Innovation: Broad incumbent - CNRS's national subsidiary handling IP valorization across all CNRS labs (including those feeding SATT Lutech); broader scope and deeper CNRS mandate, but overlapping on biotech/medtech invention disclosures from shared laboratories.
• Cambridge Enterprise: Broad incumbent - University of Cambridge's tech transfer and startup creation arm; comparable technology licensing, equity participation and seed-funding model, but globally scaled and serving one of Europe's most productive deeptech ecosystems.
• Oxford University Innovation (OUI): Broad incumbent - UK's leading university technology transfer office; comparable business model (IP licensing, equity stakes, startup creation) at much larger international scale, useful benchmark for global best-practice in academic deeptech commercialization.

Direct peers

• SATT Grand Est: Direct peer - SATT serving Grand Est universities (Strasbourg, Reims, etc.); same national SATT charter, Bpifrance-backed funding model, comparable service offers (Exploration, Synergie, Stratégie tracks), competing for technology transfer mandates and biotech/medtech startups.
• SATT Paris-Saclay: Direct peer - sister SATT covering Université Paris-Saclay ecosystem; same SAS technology transfer model, same Bpifrance-backed national network, similar co-maturation offer structure, competing for overlapping Ile-de-France deeptech startups and industrial partners.
• SATT AxLR: Direct peer - SATT serving Montpellier-area universities; identical national SATT framework, comparable co-maturation program and tech transfer services, competing for southern French deeptech commercialization mandates and biotech/agri-tech startups.
• Erganeo (formerly SATT IDF Innov): Direct peer - Ile-de-France-based SATT covering Université Paris-Saclay and Paris region; same co-maturation model, same national network, overlapping Paris geography and customer base of industrial partners, active competitor for Sorbonne-adjacent research outputs.
• SATT Nord: Direct peer - SATT covering northern French universities (Lille, etc.); comparable technology transfer mandate, same national SATT network membership, similar co-maturation funding model, competing for deeptech startups from its respective university ecosystem.
• SATT Ouest (OVSQ): Direct peer - Western France SATT (Rennes, Nantes, Brest, Le Mans); identical operating model under the national SATT network, similar co-maturation funding bands and licensing approach, competing regional player in French academic deeptech transfer.
• INRIA Transfert: Direct peer - French national tech transfer office for INRIA (digital/computer science research); same academic tech transfer mission and French public-research ecosystem, complementary on digital SATT Lutech sheets (SyncLock, MITools) but competes for digital deeptech commercialization.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/SATTLutech
• LinkedInlinkedin.com/company/satt-lutech

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SATTLutech